HC Wainwright Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […]
